In this interview, Keith Yamamoto, PhD, Director of UCSF Precision Medicine, explains why UCSF is considered a leader in the field and describes the "machine" created to fuel new insights and innovation.

The 31 UCSF speakers are among the foremost leaders who will share the latest in innovative technologies, research initiatives and clinical care developments that enable the translation of precision medicine into direct improvements in patient care.

UCSF–led research team has discovered the first conclusive evidence that natural selection may also occur at the level of the epigenome and has done so for tens of millions of years.

Children waiting for new livers who are much smaller than their peers have a heightened risk of dying. Despite this, 40 percent of these undersized waitlisted children may lose vital points required to expedite transplantation, due to a ranking system that does not account for their growth failure.

Five years after having an abortion, over 95 percent of the women in a landmark UCSF study said it was the right decision for them.